Coreline Soft signs partnership with ParagonCare… Participation in ALCC 2025

February 12, 2025 09:00 PM GMT | By Cision
 Coreline Soft signs partnership with ParagonCare… Participation in ALCC 2025
Image source: Kalkine Media
  • Strategic partnership with Australian comprehensive healthcare company ParagonCare (ASX:PGC)
  • Demonstration of global lung cancer screening optimization product AVIEW LCS Plus at ALCC 2025 to be held on the 19th
  • Consulting based on experience in winning global lung cancer screening orders in Germany, Italy, and 5 European countries

ADELAIDE, Australia and SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ -- Coreline Soft, a global leader in AI-based medical solutions, has announced its entry into Australia, one of the three major medical device markets in Asia and the Atlantic. It recently revealed a strategic partnership with ParagonCare (ASX:PGC), a leading Australian comprehensive healthcare company, and its participation in the Australian Lung Cancer Conference (ALCC 2025) to be held on the 19th.

This partnership focuses on accelerating lung cancer screening projects at major hospitals based on the Australian National Lung Cancer Screening Program, which will be launched in July, and improving the quality of healthcare services in Australia through experience in operating AI-based workflows. The two companies plan to combine ParagonCare's extensive distribution network and Coreline Soft's technological innovation to set a new standard for the Australian healthcare system.

Additionally, both Coreline Soft and ParagonCare will participate in the Australian Lung Cancer Conference (ALCC 2025) on the 19th, providing expert consulting tailored to Australia's screening environment. This conference will bring together leading Australian lung cancer researchers, clinicians, and policymakers to share the latest information and current issues in lung cancer diagnosis, treatment, and prevention. Coreline Soft plans to maximize diagnostic accuracy and establish customized treatment plans for patients by demonstrating advanced products and providing expert lung cancer consulting in cooperation with ParagonCare.

The AVIEW LCS Plus, which will be demonstrated at the conference, is a product that has already been used for national lung cancer screening in several European countries. It has a track record of improving diagnostic accuracy and operational efficiency by being optimized for large-scale diagnostic programs.

It has been supplied to national lung cancer screening projects such as Germany's HANSE, Italy's RISP, and 4ITRL, which involved five European countries, achieving significant success and accelerating the introduction of AI screening processes. Following the success of HANSE, AI has been recommended as a mandatory first-line diagnosis for lung cancer screening in Germany, with similar movements noted in major European countries including France.

"The collaboration with ParagonCare will be a significant turning point in the Australian market. By merging AI technology and medical services, we will provide better lung cancer screening solutions throughout Australia and contribute to raising awareness of the importance of early detection of lung cancer," said Jason (Junghyuck) Suh, Director of Overseas Business at Coreline Soft.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AI on the Rise: A Look at Top AI Companies and Their Stocks

Send OTP Resend OTP in 30s
Verify OTP

Sponsored Articles


Investing Ideas

Previous Next